OTCMKTS:GNBT - Generex Biotechnology News Headlines

$2.97
+0.16 (+5.69 %)
(As of 07/17/2019 04:00 PM ET)
Today's Range
$2.80
Now: $2.97
$2.99
50-Day Range
$1.0015
MA: $2.13
$3.20
52-Week Range
$0.0838
Now: $2.97
$3.28
Volume57,811 shs
Average Volume126,144 shs
Market Capitalization$104.19 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.89

Headlines

Generex Biotechnology (OTCMKTS GNBT) News Headlines

Source:
DateHeadline
Biotech’s New Rising StarBiotech’s New Rising Star
www.baystreet.ca - July 17 at 10:37 AM
Generex Biotechnology Announces Investor Conference Call Scheduled for July 25, 2019Generex Biotechnology Announces Investor Conference Call Scheduled for July 25, 2019
finance.yahoo.com - July 16 at 5:09 PM
Generex Biotechnology Subsidiary Olaregen Therapeutix Sponsors APMA Annual Scientific MeetingGenerex Biotechnology Subsidiary Olaregen Therapeutix Sponsors APMA Annual Scientific Meeting
finance.yahoo.com - July 15 at 10:20 AM
Generex Biotechnology Announces Acquisition of Pantheon Medical Foot & AnkleGenerex Biotechnology Announces Acquisition of Pantheon Medical Foot & Ankle
finance.yahoo.com - July 12 at 10:12 AM
Generex Biotechnology Announces Closing on Acquisition of MediSource PartnersGenerex Biotechnology Announces Closing on Acquisition of MediSource Partners
finance.yahoo.com - July 12 at 10:12 AM
Generex Biotechnology Announces Acquisition of Pantheon Medical Foot & AnkleGenerex Biotechnology Announces Acquisition of Pantheon Medical Foot & Ankle
finance.yahoo.com - July 11 at 9:54 AM
Generex Biotechnology Provides Fiscal Year OverviewGenerex Biotechnology Provides Fiscal Year Overview
finance.yahoo.com - July 10 at 10:15 AM
Generex Engages Donohoe Advisory to Assist with UplistingGenerex Engages Donohoe Advisory to Assist with Uplisting
finance.yahoo.com - July 2 at 10:20 AM
The Stock Day Podcast Hosts Generex Biotechnology Corporation to Discuss Uplisting on the NASDAQThe Stock Day Podcast Hosts Generex Biotechnology Corporation to Discuss Uplisting on the NASDAQ
finance.yahoo.com - July 1 at 10:11 AM
Generex Announces Update on 1:1 Dividend and NASDAQ ListingGenerex Announces Update on 1:1 Dividend and NASDAQ Listing
finance.yahoo.com - June 28 at 10:09 AM
Generex Biotechnology Subsidiary Olaregen Therapeutix Receives American Podiatry Medical Associations “Seal of Approval” for Excellagen Wound Conforming MatrixGenerex Biotechnology Subsidiary Olaregen Therapeutix Receives American Podiatry Medical Associations “Seal of Approval” for Excellagen Wound Conforming Matrix
finance.yahoo.com - June 27 at 10:19 AM
Generex Signs Letter of Intent with Kiromic to Merge with NuGenerex Immuno-Oncology Forming a Multi-Platform Clinical Stage Immunotherapy CompanyGenerex Signs Letter of Intent with Kiromic to Merge with NuGenerex Immuno-Oncology Forming a Multi-Platform Clinical Stage Immunotherapy Company
finance.yahoo.com - June 25 at 9:27 AM
Generex Investor Conference Call Recording Now Available Online Detailing 1:1 Stock Dividend, Merger for NuGenerex Immuno-Oncology and Go Forward PlansGenerex Investor Conference Call Recording Now Available Online Detailing 1:1 Stock Dividend, Merger for NuGenerex Immuno-Oncology and Go Forward Plans
finance.yahoo.com - June 24 at 6:08 PM
Generex Announces That the Pool Shares for the Benefit of Generex Will Be Retired and Put Back into the Corporate Treasury Following Payment of the 1:1 DividendGenerex Announces That the Pool Shares for the Benefit of Generex Will Be Retired and Put Back into the Corporate Treasury Following Payment of the 1:1 Dividend
finance.yahoo.com - June 21 at 5:19 PM
Generex Jumps on News of DividendGenerex Jumps on News of Dividend
www.baystreet.ca - June 20 at 5:30 PM
Generex Biotechnology declares stock dividendGenerex Biotechnology declares stock dividend
seekingalpha.com - June 20 at 10:16 AM
Generex Declares 1:1 Stock DividendGenerex Declares 1:1 Stock Dividend
finance.yahoo.com - June 20 at 10:16 AM
Reminder: Investor Conference Call Friday June 21st, 2019Reminder: Investor Conference Call Friday June 21st, 2019
finance.yahoo.com - June 17 at 11:19 AM
Generex Provides Update to Pending 1:1 Stock DividendGenerex Provides Update to Pending 1:1 Stock Dividend
finance.yahoo.com - June 7 at 6:40 PM
Generex Biotechnology CEO Joe Moscato To Present at H.C. Wainwright Healthcare ConferenceGenerex Biotechnology CEO Joe Moscato To Present at H.C. Wainwright Healthcare Conference
finance.yahoo.com - June 4 at 10:18 AM
Generex Biotechnology Announces Date for Rescheduled May 15th Investor Conference Call to Present Organizational Roadmap & Update on Investor Dividend, Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic PlansGenerex Biotechnology Announces Date for Rescheduled May 15th Investor Conference Call to Present Organizational Roadmap & Update on Investor Dividend, Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans
finance.yahoo.com - June 3 at 10:06 AM
Generex Biotechnology Announces Share Dividend & Strategic PlansGenerex Biotechnology Announces Share Dividend & Strategic Plans
finance.yahoo.com - May 31 at 10:17 AM
Generex Biotechnology Announces that its Subsidiary Olaregen Therapeutix Launches Excellagen at The Symposium on Advanced Wound Care (SAWC) in San Antonio, TXGenerex Biotechnology Announces that its Subsidiary Olaregen Therapeutix Launches Excellagen at The Symposium on Advanced Wound Care (SAWC) in San Antonio, TX
finance.yahoo.com - May 16 at 10:40 AM
Generex Biotechnology Announces Postponement of Its May 15th Investor Conference CallGenerex Biotechnology Announces Postponement of Its May 15th Investor Conference Call
finance.yahoo.com - May 15 at 10:08 AM
Generex Biotechnology Subsidiary NuGenerex Diagnostics Announces Sales for its Rapid Point-of-Care Malaria Diagnostic Test KitGenerex Biotechnology Subsidiary NuGenerex Diagnostics Announces Sales for its Rapid Point-of-Care Malaria Diagnostic Test Kit
finance.yahoo.com - May 2 at 10:20 AM
Generex Biotechnology Subsidiary Olaregen Therapeutix Sponsors Prestigious Diabetic Limb Salvage Conference in Washington D.C.Generex Biotechnology Subsidiary Olaregen Therapeutix Sponsors Prestigious Diabetic Limb Salvage Conference in Washington D.C.
finance.yahoo.com - April 18 at 5:45 PM
Kali-Extracts To Present Cannabis Treatment R&D For $170 Million In Pharmaceutical Market Opportunity On April 17thKali-Extracts To Present Cannabis Treatment R&D For $170 Million In Pharmaceutical Market Opportunity On April 17th
finance.yahoo.com - April 9 at 5:58 PM
Generex Biotechnology Corporation Appoints Mark J. Prioletti to the Board of DirectorsGenerex Biotechnology Corporation Appoints Mark J. Prioletti to the Board of Directors
finance.yahoo.com - April 8 at 10:45 AM
Generex Addresses Shareholder Concern Over 8-K and Quarterly FilingGenerex Addresses Shareholder Concern Over 8-K and Quarterly Filing
finance.yahoo.com - April 4 at 5:44 PM
Upmarket Deal at $2.50 Per Share Saves Generex Biotechnology Shareholders $14+ MillionUpmarket Deal at $2.50 Per Share Saves Generex Biotechnology Shareholders $14+ Million
finance.yahoo.com - March 29 at 10:36 AM
Generex Biotechnology Partner Olaregen Therapeutix, Inc. Selected to Present a Formal Poster Session at Prestigious Diabetic Limb Salvage MeetingGenerex Biotechnology Partner Olaregen Therapeutix, Inc. Selected to Present a Formal Poster Session at Prestigious Diabetic Limb Salvage Meeting
finance.yahoo.com - March 26 at 10:32 AM
USMJ and PURA Update Dividend Distribution Plans With PJET and NOUV To Include New Developments With WCVC and KALYUSMJ and PURA Update Dividend Distribution Plans With PJET and NOUV To Include New Developments With WCVC and KALY
finance.yahoo.com - March 22 at 5:31 PM
KALY Phase One Cannabis Extract COPD Research To Be Published This Friday, March 22, 2019KALY Phase One Cannabis Extract COPD Research To Be Published This Friday, March 22, 2019
finance.yahoo.com - March 20 at 5:40 PM
Generex Biotechnology CorpGenerex Biotechnology Corp
www.bloomberg.com - March 18 at 5:48 PM
KALY Initiates Phase Two Cannabis Extract COPD Treatment StudyKALY Initiates Phase Two Cannabis Extract COPD Treatment Study
finance.yahoo.com - March 18 at 5:48 PM
KALY Cannabis Patent Featured In PURA Report On Progress Toward $5 Million Sales GoalKALY Cannabis Patent Featured In PURA Report On Progress Toward $5 Million Sales Goal
finance.yahoo.com - March 8 at 5:29 PM
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces the Appointment of Vice President of Business StrategyGenerex Biotechnology Subsidiary Olaregen Therapeutix Announces the Appointment of Vice President of Business Strategy
finance.yahoo.com - March 8 at 10:42 AM
Puration Signs New CBD Beverage Distribution Orders With Even Bigger Orders Underway Fueling M&A InterestPuration Signs New CBD Beverage Distribution Orders With Even Bigger Orders Underway Fueling M&A Interest
finance.yahoo.com - March 7 at 11:09 AM
Generex Investor Conference Call Now Available OnlineGenerex Investor Conference Call Now Available Online
finance.yahoo.com - March 1 at 10:47 AM
PURA - Puration Announces Analyst Update Report Coming Thursday February 28, 2019PURA - Puration Announces Analyst Update Report Coming Thursday February 28, 2019
finance.yahoo.com - February 26 at 5:11 PM
Reminder: Investor Conference Call Today, February 26, 2019; Management to Provide Update on Initiatives & Strategic Plans, Call-in DetailsReminder: Investor Conference Call Today, February 26, 2019; Management to Provide Update on Initiatives & Strategic Plans, Call-in Details
finance.yahoo.com - February 26 at 10:53 AM
KALY – Kali-Extracts, Inc. Previews Pending Report On Cannabis Treatment For Lung Disease StudyKALY – Kali-Extracts, Inc. Previews Pending Report On Cannabis Treatment For Lung Disease Study
finance.yahoo.com - February 21 at 11:47 AM
Generex Biotechnology Subsidiary Regentys Corporation Receives Approval of Japanese Patent for Extracellular Matrix Hydrogel (Regentys ECMH™)Generex Biotechnology Subsidiary Regentys Corporation Receives Approval of Japanese Patent for Extracellular Matrix Hydrogel (Regentys ECMH™)
finance.yahoo.com - February 19 at 10:40 AM
Generex Biotechnology Announces Investor Conference Call Agenda; Tuesday, February 26, at 11:00 A.M. EasternGenerex Biotechnology Announces Investor Conference Call Agenda; Tuesday, February 26, at 11:00 A.M. Eastern
finance.yahoo.com - February 15 at 10:58 AM
Generex Announces Appointment of Marshal Schictman, Esq. as Executive Vice President General Counsel and Corporate SEC AttorneyGenerex Announces Appointment of Marshal Schictman, Esq. as Executive Vice President General Counsel and Corporate SEC Attorney
finance.yahoo.com - February 12 at 10:35 AM
KALY – Kali-Extracts, Inc. Publishes Cannabis Extract Lung Disease Treatment Study PreviewKALY – Kali-Extracts, Inc. Publishes Cannabis Extract Lung Disease Treatment Study Preview
finance.yahoo.com - February 5 at 4:56 PM
Generex in dispute with debt holder demanding immediate repaymentGenerex in dispute with debt holder demanding immediate repayment
seekingalpha.com - February 4 at 5:00 PM
Generex Biotechnology Responds to Demand for PaymentGenerex Biotechnology Responds to Demand for Payment
finance.yahoo.com - February 4 at 5:00 PM
KALY - Kali-Extracts, Inc. Announces Cannabis Extract COPD Primate Treatment Study Research Report PreviewKALY - Kali-Extracts, Inc. Announces Cannabis Extract COPD Primate Treatment Study Research Report Preview
finance.yahoo.com - February 1 at 10:27 AM
KALY Releases Update Highlighting Potential In $14 Billion COPD Treatment Market and Additional Pharmaceutical MarketsKALY Releases Update Highlighting Potential In $14 Billion COPD Treatment Market and Additional Pharmaceutical Markets
finance.yahoo.com - January 30 at 5:06 PM
This page was last updated on 7/17/2019 by MarketBeat.com Staff

Featured Article: What is the Current Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel